Veno-occlusive disease and primary hepatic vein thrombosis in Israeli Arabs.
In a survey of nine major Israeli hospitals, 29 patients diagnosed between 1955 and 1975 as suffering from hepatic vein thrombosis were identified. Fifteen of the patients were Jews and 14 were Arabs. In contrast to the Jewish patients, all of whom were adults, the majority of the Arab patients were children below 10 years of age. Primary hepatic vein occlusion was 2.4 times more common among Arab than among Jewish patients. Of the 11 Arab patients with primary hepatic vein occlusion, three had histological changes typical of veno-occlusive disease; whereas in five others, thrombotic occlusion of large hepatic veins or of the vena cava was documented. Although no plant alkaloids could be directly implicated in any of the Arab patients, circumstantial evidence strongly supports such an etiology. All of our Arab patients originated from small agricultural communities where ancient methods of winnowing, which expose the home-ground wheat to a high risk of contamination by grains containing pyrrolizidine alkaloids, are still in use. This report confirms the world-wide distribution of veno-occlusive disease, and under-lines the need for a systematic search for possible sources of poisoning by pyrrolizidine alkaloids.
D000293:Adolescent; D000328:Adult; D006502:Budd-Chiari Syndrome / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D005006:Ethnicity; D005260:Female; D006503:Hepatic Veins / Q000473:pathology; D006529:Hepatomegaly; D006801:Humans; D007557:Israel; D007585:Jews; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011763:Pyrrolizidine Alkaloids / Q000009:adverse effects; D013924:Thrombophlebitis / Q000175:diagnosis* / Q000473:pathology
D011763:Pyrrolizidine Alkaloids